Loading...

Purified Mouse IgG1, κ Isotype Ctrl Antibody

Pricing & Availability
Clone
MG1-45 (See other available formats)
Regulatory Status
RUO
Isotype
Mouse (BALB/c) IgG1, κ
Ave. Rating
Submit a Review
Product Citations
publications
MG1-45_GoChIP_IgG1_Iso-Con_060618_updated.png
Chromatin Immunoprecipitations (ChIP) were performed with cross-linked chromatin samples from 4 X 106 of Jurkat cells with either A)1:100 dilution of Go-ChIP-Grade™ Purified anti-HDAC1 (Clone 10E2/HDAC1, Cat. No. 815103) or B) equal amount of Go-ChIP-Grade™ Purified Mouse IgG1, κ Isotype Control Antibody (Clone MG1-45, Cat. No. 401409) by using Go-ChIP-Grade™ Protein G Enzymatic Kit (Cat. No. 699904). The enriched DNA was purified and quantified by real-time qPCR using primers targeting human CDKN1A gene region and α-Satellite repeats. The amount of immunoprecipitated DNA in each sample is represented as signal relative to total amount of input chromatin.
  • MG1-45_GoChIP_IgG1_Iso-Con_060618_updated.png
    Chromatin Immunoprecipitations (ChIP) were performed with cross-linked chromatin samples from 4 X 106 of Jurkat cells with either A)1:100 dilution of Go-ChIP-Grade™ Purified anti-HDAC1 (Clone 10E2/HDAC1, Cat. No. 815103) or B) equal amount of Go-ChIP-Grade™ Purified Mouse IgG1, κ Isotype Control Antibody (Clone MG1-45, Cat. No. 401409) by using Go-ChIP-Grade™ Protein G Enzymatic Kit (Cat. No. 699904). The enriched DNA was purified and quantified by real-time qPCR using primers targeting human CDKN1A gene region and α-Satellite repeats. The amount of immunoprecipitated DNA in each sample is represented as signal relative to total amount of input chromatin.
Cat # Size Price Quantity Check Availability Save
401401 50 µg 38€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
401402 500 µg 104€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

The isotype of MG1-45 immunoglobulin is mouse IgG1, κ. It was chosen as an isotype control after screening on a variety of resting, activated, live, and fixed mouse, rat and human tissues.

Product Details
Technical Data Sheet (pdf)

Product Details

Antibody Type
Monoclonal
Host Species
Mouse
Immunogen
Trinitrophenol + KLH
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The immunoglobulin was purified by affinity chromatography.
Concentration
0.5 mg/mL
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC, ICFC - Quality tested
ChIP - Verified
WB, IP, ICC, IHC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis as negative control, and the purity is greater than 95% by SDS-PAGE. Use at concentrations comparable to those of the specific antibody of interest.

Application Notes

The MG1-45 immunoglobulin is useful as an isotype-matched control (for the relevant formats) for Western blotting, immunoprecipitation, immunohistochemistry, functional assay, immunofluorescence microscopy, immunocytochemistry and immunofluorescent staining (surface or intracellular) for flow cytometric analysis. The LEAF™ purified antibody (Endotoxin <0.1 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 401404) as negative control. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 401408) with a lower endotoxin limit than standard LEAF™ purified antibodies (Endotoxin <0.01 EU/µg).

Application References
  1. Ozeki M, et al. 2008. J. Leukocyte Biol. 84:769. PubMed
  2. Kraetzel K, et al. 2008. Eur. Respair. J. 32:563. PubMed
  3. de Jong MA, et al. 2008. J Gen Virol. 89:2398. PubMed
  4. Romee R, et al. 2012 Blood. 120:4751. PubMed.
  5. Wong-Baeza I, et al. 2013. J. Immunol. 190:3216. PubMed.
Product Citations
  1. Gargaro M, et al. 2022. Immunity. 55:1032. PubMed
  2. Howson LJ, et al. 2018. Nat Commun. 9:253. PubMed
  3. Frasca D, et al. 2020. Front Immunol. 11:392. PubMed
  4. Staessens S, et al. 2022. J Thromb Haemost. 20:2058. PubMed
  5. Lao L, et al. 2023. Cancer Immunol Res. 11:320. PubMed
  6. El-Husseiny HM, et al. 2023. Int J Mol Sci. 24:. PubMed
  7. Wischnewski V, et al. 2023. Nat Cancer. . PubMed
  8. Gabaev I, et al. 2020. Cell Rep. 33:108249. PubMed
  9. Willcox CR, et al. 2020. Immunity. 51(5):813-825.e4.. PubMed
  10. Melo-Gonzalez F, et al. 2018. J Biol Chem. 293:8543. PubMed
  11. Fielding CA et al. 2017. eLife. 6 pii: e22206. PubMed
  12. Korn MA, et al. 2020. J Immunol. 205:2595. PubMed
  13. Ai K, et al. 2022. PLoS Pathog. 18:e1010913. PubMed
  14. Wong-Baeza I, et al. 2013. J Immunol. 190:3216. PubMed
  15. Bradford BM, et al. 2018. Parasite Immunol. 40:e12566. PubMed
  16. Sithole N, et al. 2020. Retrovirology. 17:6. PubMed
  17. Evesson F, et al. 2010. J Biol Chem. 285:28529. PubMed
  18. Adeniran BV, et al. 2021. Hum Reprod. 36:1871. PubMed
  19. Wahlig S, et al. 2020. Sci Rep. 1.584027778. PubMed
  20. Sun Z, et al. 2017. J Physiol. 595:1987. PubMed
  21. Subramaniyan B, et al. 2021. Viruses. 13:. PubMed
  22. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  23. Kimura T, et al. 2020. Commun Biol. 0.527777778. PubMed
  24. Pir GJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  25. Wallis J, et al. 2020. Eur J Pharm Sci. 152:105456. PubMed
  26. Han N, et al. 2021. STAR Protocols. 2(2):100460. PubMed
  27. Seoane M, et al. 2019. Oncogene. 38:3616. PubMed
  28. Hangiu O, et al. 2022. iScience. 25:104958. PubMed
  29. Ji Y, et al. 2012. J Biol Chem. 287:24378. PubMed
  30. Wang F, et al. 2020. Int J Oncol. 57:707. PubMed
  31. Essig F, et al. 2020. Int J Mol Sci. 21:00. PubMed
  32. Camilli G, et al. 2020. J Clin Invest. 130:4561. PubMed
  33. Huang CH, et al. 2019. ACS Nano. 13:11698. PubMed
  34. Munoz O, et al. 2022. PLoS Pathog. 18:e1010673. PubMed
  35. Matsuba S, et al. 2017. Front Immunol. . 10.3389/fimmu.2017.01538. PubMed
  36. Fetz AE, et al. 2021. Acta Biomater. 130:281. PubMed
  37. Lavie L, et al. 2022. Front Neurol. 13:811916. PubMed
  38. Barzilai S, et al. 2016. J Leukoc Biol. 99: 1045 - 1055. PubMed
  39. Vermi W, et al. 2018. Cancer Res. 78:3544. PubMed
  40. Satchwell TJ, et al. 2019. Nat Commun. 10:3806. PubMed
  41. Nasser H, et al. 2022. STAR Protoc. 3:101773. PubMed
  42. Gopinath A, et al. 2021. NPJ Parkinsons Dis. 7:62. PubMed
  43. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  44. Suzuki R, et al. 2022. Nature. . PubMed
  45. Meyrath M, et al. 2020. Nat Commun. 2.564583333. PubMed
  46. Jong M, et al. 2008. J Gen Virol. 89:2398. PubMed
  47. Hori Y, et al. 2022. Front Cardiovasc Med. 9:981088. PubMed
  48. Rolfes V, et al. 2020. Cell Reports. 31(6):107615. PubMed
  49. Staessens S, et al. 2019. Haematologica. 104(10). PubMed
  50. Doni A, et al. 2021. Nat Commun. 12:3739. PubMed
  51. Maleki KT, et al. 2021. Cell Reports Medicine. 2(3):100220. PubMed
  52. Cao Y, et al. 2019. Nat Commun. 10:1280. PubMed
  53. Enomoto Y, et al. 2021. Cancer Gene Ther. Online ahead of print. PubMed
  54. Murayama M, et al. 2015. Nat Commun. 6: 8483. PubMed
  55. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  56. Demetriou P, et al. 2020. Nat Immunol. 1232:21. PubMed
  57. Camilli G, et al. 2018. Eur J Immunol. 48:757. PubMed
  58. Yakymiv Y, et al. 2021. Sci Rep. 11:21230. PubMed
  59. Huang Y, et al. 2021. Front Immunol. 12:649502. PubMed
  60. Kraetzel K, et al. 2008. Eur Respir J. 32:563. PubMed
  61. Shively M 2008. J Leukoc Biol. 84:769. PubMed
  62. Parashar D, et al. 2019. Cell Rep. 29:4389. PubMed
  63. Uttagomol J, et al. 2019. Int J Mol Sci. 5.153472222. PubMed
  64. Romee R, et al. 2012. Blood. 120:4751. PubMed
  65. Wülfing C, et al. 2018. Immun Inflamm Dis. 0.495833333. PubMed
  66. Galeano Nio JL, et al. 2020. eLife. 9:00. PubMed
  67. Kauer J, et al. 2019. Sci Rep. 9:18337. PubMed
  68. Espinosa-Díez C, et al. 2018. Redox Biol. 14:88. PubMed
RRID
AB_2801452 (BioLegend Cat. No. 401401)
AB_2801451 (BioLegend Cat. No. 401402)

Antigen Details

Gene ID
NA

Other Formats

View All Reagents
Description Clone Applications
Purified Mouse IgG1, κ Isotype Ctrl MG1-45 FC,ICFC,ICC,IHC,IP,WB,ChIP
Ultra-LEAF™ Purified Mouse IgG1, κ Isotype Ctrl MG1-45 FC,ICFC,WB,IP,ICC,IHC,FA
Go To Top Version: 3    Revision Date: 08.24.2021

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account